Stetson et al. used scRNA-seq to analyze differences between matched samples (collected at initial diagnosis and again at relapse) in five different AML patients, and found characteristic RNA changes with AML progression, such as high expression of CD44, HLAs, and PTMA [93]. Here, CD44 is linked to acute myeloid leukemia.